Farzin Roohvand received his Ph.D in Biotechnology from Middle East Technical Univ. (Ankara-Turkey) in 1998 and started his career in Hepatitis and AIDS Dept. of Pasteur Institute of Iran since 1999. During 2002-2003 he did his First Post-doc studies in Molecular medicine and Carcinogenic hepatitis Unit of Paris Pasteur Institute in the domain of Hepatitis C and later during 2004-2005 he served as a guest scientist in Unité Hépacivirus of Pasteur Institute in Paris. During 2008-2010 he worked in the same Institute and unit as Principal investigator and confirmed international scientist supported by ANRS (Agence National de Research sur SIDA et Hepatit Viral - France). During this period his works resulted to identification of the role of microtubules in HCV infection. Since 2012, he served as an associated Prof and since 2020, as a full professor of Biotechnology and Mol. Virology and principal investigator in Virology Dept. of Pasteur Institute of Iran. He has been author of a number of international articles and book chapters in the domain of Molecular virology and biotechnology and supervised several Ph.D and master theses. He  served as invited speaker for specially presenting key note lectures in the domain of HCV vaccines and is author of review articles in this domain in “Expert Opinion” series. Dr. Roohvand has received several academic honors and prizes. Currently, Dr. Roohvand serves in Editorial Board of several scientific Journals”.  He has reviewed/handled hundreds of research articles for recognized scientific journals.